Home of skin cancer education

Directed by dermatologists & dermatopathologists

 

Sunset from the ACCO Centre, Melbourne CBD

The Australasian College of Cutaneous Oncology provides practical and theory-based training and education to improve and certify competency in the management of skin cancer. Our policy is that no pharmaceutical company shall be permitted to sponsor or endorse any event, function or workshop in any manner.  This creates a truly unique and unbiased learning environment.


Covid 19 - ACCO suspends programs for 6 mths

  • All ACCO programs including workshops scheduled for April and July 2020 have been postponed
  • The Essentials workshop will now take place on Friday September 18 and Saturday September 19
  • The Dermoscopy workshop will now take place on Saturday September 19 and Sunday September 20
  • The Combined Essentials and Dermosopcy workshops can be completed back to back on September 18 / 19 / 20
  • The Flap and Graft workshop will now take place over the five days: October 30 / 31 and November  1 / 2 / 3
  • As a result of workshop shifts :-
  • ACCO offer full flexibility to those already registered for April or July events prior to March 26, 2020. Registrants can choose to:
    • Withdraw from the workshop and recieve a full refund within four weeks
    • Move your registration to the new September / October / November dates with guaranteed registration acceptance along with a 10% discount of your registration fee in recognition of the inconvenience the date changes have caused. Registrants who have already paid in full will recieve a 10% refund within the next four weeks
    • Please notify ACCO of your choice at your earliest convenience to admin@acco.edu.au 


COVID - 19 Do I need to alter my skin cancer management?

As of March 26, 2020, ACCO recommends: 

  1. Limit skin cancer checks to patients with a past history of melanoma and other high risk patients
  2. Thorough hand washing is essential before and after each skin check. Consider usage of gloves
  3. Polarised dermoscopy allows no contact between patient and instrument. This can be an advantage in these situations
  4. Delay procedures to manage minor lesions including SCC in situ and superficial BCCs
  5. Surgery for wide local excision of melanoma or invasive SCC should not be delayed on this basis alone
  6. Health care professionals who are required to self isolate should not recommence face to face patient contact until their isolation period is complete
  7. Consider reception triaging patients need for skin checks. Low risk patients can be asked to book at a later date
  8. Reception triage process can include whether patient meets the Government criteria to quarantine / home isolation. This includes any person in Australia who has been outside of Australia in the last 14 days. The same applies in New Zealand  to anyone outside of NZ in the last 14 days.  
  9. Any patient unwell with upper respiratory symptoms and / or fever should have a skin check deferred 
  10. Consider asking patients to wait in the car for their appointment. The staff can ring them in the car to attend as appropriate, minimising the number of patients in the waiting room. 

The Australian Journal of General Practice inappropriately retracts two ACCO publications on melanoma commissioned by the journal's Editor in Chief.

Details here   

Read our full rebuttal to the manuscript retractions here.


ACCO CRITICAL OF DRAFT WIKI GUIDELINES ON BCC & SCC


The ACCO item number ready reckoner:

ACCO 'ready reckoner' page 1     

ACCO 'ready reckoner' page 2


Assessing melanoma mortality risk - chart 

Vitamin B3 advice to our patients:-

Download the ACCO patient education sheet here.


The ACCO Mission

  • Workshops of quality  to further educate doctors & nurses
  • Examine and assess competence in managing skin cancer
  • Donate all proceeds over costs to medical research
  • All with the highest standards of impartiality


ACCO Certifications Pathway

Associate Fellow of ACCO
Fellow  of ACCO


RESEARCH 

In 2018 ACCO researchers published a renewed set off guidelines for appropriate management of superficial BCC and squamous cell carcinoma in situ. This was published in JAMA Dermatology. 

FUNDING OUR RESEARCH

ACCO does not accept any funding from Governments, Universities or the Pharmaceutical industry. ACCO uses revenue from workshops to fund our ongoing research programs. Even our published drug trials were completed without drug company funding. ACCO regards true independence as critical. Even funding from Governments is tainted.. Governments have a vested interest in cheaper treatments or no treatments working as well as expensive methods. Without Government influence, ACCO research has often found that no treatment is superior to expensive treatments. 

© ACCO All rights retained - Founded in Victoria in 2006